The strain A anti-p-azophenylarsonate major cross-reactive idiotypic family includes members with no reactivity toward p-azophenylarsonate

European Journal of Immunology
L J Wysocki, V L Sato

Abstract

The sera of immunized A/J mice contain low but detectable levels of immunoglobulin, bearing previously described cross-reactive idiotypic (CRI) determinants diagnostic of the strain A anti-p-azophenylarsonate (Ars) response. Such molecules from nonimmune sera cannot be adsorbed onto affinity columns coupled to a high density with Ars. After extensive immunization with Ars-coupled proteins, Ars-nonbinding CRI is found at the same low level, even though substantial Ars-binding CRI appears. On the other hand, immunization with a monoclonal rat anti-CRI, which was originally raised against Ars-binding CRI, elicits high concentrations of Ars-binding as well as Ars-nonbinding CRI immunoglobulin. Three hybridoma proteins produced from an A/J mouse immunized with the rat anti-CRI react with all tested anti-idiotypic sera from three species of animals, but show no reactivity toward Ars in several different assays. One hybridoma protein from the same fusion demonstrates Ars-binding capacity.

References

May 1, 1977·European Journal of Immunology·H CosenzaM H Julius
Nov 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J UrbainC Collignon
Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·L J Wysocki, V L Sato
Oct 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J A LaskinP D Gottlieb
Mar 1, 1977·Somatic Cell Genetics·M L GefterM D Scharff
Apr 1, 1976·European Journal of Immunology·G KöhlerC Milstein
Oct 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·J Oudin, P A Cazenave
Apr 1, 1973·The Journal of Experimental Medicine·L L Pawlak, A Nisonoff
Jul 1, 1974·Analytical Biochemistry·S C MarchP Cuatrecasas
Dec 22, 1967·Science·K Catt, G W Tregear
Feb 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A Marshak-RothsteinM L Gefter

❮ Previous
Next ❯

Citations

Feb 25, 1983·Journal of Immunological Methods·G Morahan
Jun 1, 1983·Molecular Immunology·D S PisetskyS Caster
Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D A Nemazee, V L Sato
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·K NakanishiT Kishimoto
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J A BluestoneD H Sachs
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·T Manser, M L Gefter
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J SharonM Ptashne
Sep 1, 1983·The Journal of Experimental Medicine·P Legrain, G Buttin
Mar 1, 1985·Vaccine·K C McCullough, D Langley
Jan 1, 1993·International Reviews of Immunology·J SharonS R Sompuram
Feb 1, 1987·Scandinavian Journal of Immunology·C Manzo, A Nisonoff
Jan 1, 1983·Annals of the New York Academy of Sciences·M N MargoliesM L Gefter
Jan 1, 1983·Annals of the New York Academy of Sciences·G K LewisJ W Goodman
Aug 24, 2010·Immunological Reviews·Yuval YarkoniJohn C Cambier
May 30, 2020·Immunological Reviews·Jackson S TurnerIrina L Grigorova
Oct 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katja AviszusLawrence J Wysocki
Aug 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Taras LyubchenkoJohn C Cambier
Nov 1, 1982·European Journal of Immunology·M C Barrett, A Nisonoff
Jan 1, 1983·Annals of the New York Academy of Sciences·J PèneM Stanislawski
Jun 1, 1983·Clinical Immunology and Immunopathology·D Pisetsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.